...
首页> 外文期刊>Cardiovascular Diabetology >Age- and sex-specific prevalence and ten-year risk for cardiovascular disease of all 16 risk factor combinations of the metabolic syndrome - A cross-sectional study
【24h】

Age- and sex-specific prevalence and ten-year risk for cardiovascular disease of all 16 risk factor combinations of the metabolic syndrome - A cross-sectional study

机译:代谢综合征的所有16种危险因素组合的年龄和性别特定患病率和十年心血管疾病风险-横断面研究

获取原文

摘要

Background Based on the AHA/NHLBI-definition three out of five cardiometabolic traits must be present for the diagnosis of the metabolic syndrome (MetS), resulting in 16 different combination types. The associated cardiovascular risk may however be different and specific combination may be indicative of an increased risk, furthermore little is known to which extent these 16 combinations contribute to the overall prevalence of MetS. Here we assessed the prevalence of all 16 combination types of MetS, analyzed the impact of age and gender on prevalence rates, and estimated the 10-year risk of fatal and non-fatal myocardial infarction (MI) of each MetS combination type. Methods We used data of the German Metabolic and Cardiovascular Risk Project (GEMCAS), a cross-sectional study, performed during October 2005, including 35,869 participants (aged 18-99 years, 61% women). Age-standardized prevalence and 10-year PROCAM and ESC risk scores for MI were calculated. Results In both men and women the combination with elevated waist-circumference, blood pressure and glucose (WC-BP-GL) was the most frequent combination (28%), however a distinct unequal distribution was observed regarding age and sex. Any combination with GL was common in the elderly, whereas any combination with dyslipidemia and without GL was frequent in the younger. Men without MetS had an estimated mean 10-year risk of 4.7% (95%-CI: 4.5%-4.8%) for MI (PROCAM), whereas the mean 10-year risk of men with MetS was clearly higher (age-standardized 7.9%; 7.8-8.0%). In women without MetS the mean 10-year risk for MI was 1.1%, in those with MetS 2.3%. The highest impact on an estimated 10-year risk for MI (PROCAM) was observed with TG-HDL-GL-BP in both sexes (men 14.7%, women 3.9%). However, we could identify combinations with equal risks of non-fatal and fatal MI compared to participants without MetS. Conclusions We observed large variations in the prevalence of all 16 combination types and their association to cardiovascular risk. The importance of different combinations of MetS changes with age and between genders putting emphasis on a tailored approach towards very young or very old subjects. This knowledge may guide clinicians to effectively screen individuals and prioritize diagnostic procedures depending on age and gender.
机译:背景技术基于AHA / NHLBI定义,必须存在五分之三的心脏代谢特征才能诊断代谢综合征(MetS),从而产生16种不同的组合类型。但是,相关的心血管疾病风险可能不同,特定的组合可能表明风险增加,此外,人们对这16种组合在多大程度上影响MetS的患病率知之甚少。在这里,我们评估了所有16种MetS组合类型的患病率,分析了年龄和性别对患病率的影响,并评估了每种MetS组合类型的致命性和非致命性心肌梗塞(MI)的10年风险。方法我们使用了2005年10月进行的横断面研究德国代谢和心血管风险项目(GEMCAS)的数据,其中包括35869名参与者(年龄18-99岁,女性占61%)。计算了年龄标准化的患病率以及MI的10年PROCAM和ESC风险评分。结果在男性和女性中,腰围,血压和血糖升高(WC-BP-GL)的组合都是最常见的组合(28%),但是在年龄和性别上观察到明显的不均等分布。与GL的任何组合在老年人中很常见,而与血脂异常和无GL的任何组合在年轻人中很常见。没有MetS的男性的十年平均MI(PROCAM)风险估计为4.7%(95%-CI:4.5%-4.8%),而患有MetS的男性的十年平均风险明显更高(年龄标准化) 7.9%; 7.8-8.0%)。在没有MetS的女性中,发生MI的10年平均风险为1.1%,在MetS的女性中为2.3%。 TG-HDL-GL-BP在男女中对估计的MI十年风险的最大影响(男性)为14.7%,女性为3.9%。但是,与没有MetS的参与者相比,我们可以确定非致命性和致命性MI风险相同的组合。结论我们观察到所有16种组合类型的患病率及其与心血管风险的关联均存在很大差异。 MetS不同组合的重要性随着年龄和性别的变化而变化,强调针对年幼或年老受试者的量身定制方法。这些知识可以指导临床医生根据年龄和性别有效地筛查患者并确定诊断程序的优先级。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号